🇺🇸 FDA
Pipeline program

Fipaxalparant, Film-coated tablet, Major Ingredients Mannitol, microcrystalline cellulose, magnesium stearate, polyvinyl alcohol, macrogol, titanium dioxide and talc

HZNP-HZN-825-303

Phase 2 small_molecule active

Quick answer

Fipaxalparant, Film-coated tablet, Major Ingredients Mannitol, microcrystalline cellulose, magnesium stearate, polyvinyl alcohol, macrogol, titanium dioxide and talc for Idiopathic Pulmonary Fibrosis is a Phase 2 program (small_molecule) at Elan Pharma International with 1 ClinicalTrials.gov record(s).

Program details

Company
Elan Pharma International
Indication
Idiopathic Pulmonary Fibrosis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials